ZW10
gene geneOn this page
Also known as KNTC1AP
Summary
ZW10 (zw10 kinetochore protein, HGNC:13194) is a protein-coding gene on chromosome 11q23.2, encoding Centromere/kinetochore protein zw10 homolog (O43264). Essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis. It is a selective cancer dependency (DepMap: 26.8% of cell lines).
This gene encodes a protein that is one of many involved in mechanisms to ensure proper chromosome segregation during cell division. This protein is an essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis.
Source: NCBI Gene 9183 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 111 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 26.8% of screened cell lines
- MANE Select transcript:
NM_004724
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13194 |
| Approved symbol | ZW10 |
| Name | zw10 kinetochore protein |
| Location | 11q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KNTC1AP |
| Ensembl gene | ENSG00000086827 |
| Ensembl biotype | protein_coding |
| OMIM | 603954 |
| Entrez | 9183 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 nonsense_mediated_decay
ENST00000200135, ENST00000535142, ENST00000538209, ENST00000898960, ENST00000898961, ENST00000936157, ENST00000946662
RefSeq mRNA: 1 — MANE Select: NM_004724
NM_004724
CCDS: CCDS8363
Canonical transcript exons
ENST00000200135 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000747318 | 113747531 | 113747713 |
| ENSE00000747322 | 113760209 | 113760368 |
| ENSE00000747324 | 113760513 | 113760590 |
| ENSE00000747325 | 113760817 | 113760918 |
| ENSE00000930586 | 113736620 | 113736822 |
| ENSE00000930587 | 113737572 | 113737703 |
| ENSE00000930588 | 113738264 | 113738394 |
| ENSE00000930589 | 113739213 | 113739382 |
| ENSE00000930590 | 113741694 | 113741765 |
| ENSE00000930591 | 113743802 | 113744040 |
| ENSE00001130190 | 113733187 | 113733814 |
| ENSE00001210656 | 113768833 | 113768967 |
| ENSE00002241311 | 113773562 | 113773692 |
| ENSE00003636877 | 113758554 | 113758706 |
| ENSE00003641773 | 113757662 | 113757853 |
| ENSE00003683396 | 113748257 | 113748420 |
Expression profiles
Bgee: expression breadth ubiquitous, 234 present calls, max score 86.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.3611 / max 201.7010, expressed in 1792 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122353 | 16.0991 | 1790 |
| 122354 | 0.2280 | 75 |
| 122355 | 0.0340 | 6 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 86.87 | silver quality |
| ventricular zone | UBERON:0003053 | 86.70 | gold quality |
| secondary oocyte | CL:0000655 | 86.62 | gold quality |
| ileal mucosa | UBERON:0000331 | 85.44 | gold quality |
| gastrocnemius | UBERON:0001388 | 85.26 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.17 | gold quality |
| muscle of leg | UBERON:0001383 | 84.86 | gold quality |
| cartilage tissue | UBERON:0002418 | 84.81 | gold quality |
| skin of leg | UBERON:0001511 | 84.00 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.43 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.29 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.98 | gold quality |
| skin of abdomen | UBERON:0001416 | 82.54 | gold quality |
| rectum | UBERON:0001052 | 82.37 | gold quality |
| body of pancreas | UBERON:0001150 | 82.22 | gold quality |
| zone of skin | UBERON:0000014 | 82.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 81.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 81.84 | gold quality |
| oocyte | CL:0000023 | 81.83 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.80 | gold quality |
| stromal cell of endometrium | CL:0002255 | 81.44 | gold quality |
| monocyte | CL:0000576 | 81.25 | gold quality |
| esophagus mucosa | UBERON:0002469 | 81.21 | gold quality |
| upper leg skin | UBERON:0004262 | 81.20 | gold quality |
| leukocyte | CL:0000738 | 81.02 | gold quality |
| mononuclear cell | CL:0000842 | 81.02 | gold quality |
| pancreas | UBERON:0001264 | 80.99 | gold quality |
| embryo | UBERON:0000922 | 80.92 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 80.35 | gold quality |
| minor salivary gland | UBERON:0001830 | 80.27 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.26 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): GATA3
miRNA regulators (miRDB)
24 targeting ZW10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-2116-5P | 99.32 | 69.34 | 1273 |
| HSA-MIR-6828-5P | 99.31 | 69.21 | 1433 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-1264 | 99.25 | 66.81 | 1317 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-7854-3P | 99.08 | 66.26 | 1117 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-4703-5P | 98.53 | 70.13 | 1645 |
| HSA-MIR-3942-5P | 98.52 | 69.51 | 1517 |
| HSA-MIR-6792-3P | 98.41 | 66.86 | 1359 |
| HSA-MIR-6892-5P | 97.27 | 68.60 | 847 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 26.8% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 13)
- Overexpression, microinjection and knockdown experiments revealed that ZW10 is involved in membrane trafficking between the endoplasmic reticulum and Golgi (PMID:15029241)
- show that ZW10 interacting protein-1(Zwint-1) is required and is sufficient for kinetochore localization of Zeste White 10 (ZW10) in HeLa cells (PMID:15485811)
- ZW10 serves as a general regulator of dynein function throughout the cell cycle. (PMID:16505164)
- RINT-1 coordinates the localization and function of ZW10 by serving as a link between ZW10 and the SNARE complex comprising syntaxin 18. (PMID:16571679)
- targeting of ZW10 to the perinuclear Golgi region was found to depend on the perinuclear accumulation of dynactin (PMID:17560939)
- RNAi-mediated depletion of ZW10 markedly-reduced congression efficiency. (PMID:17680027)
- Rab6 regulates distinct Golgi trafficking pathways involving two separate protein complexes: ZW10/RINT-1 and COG. (PMID:17699596)
- Accumulation of ZW10 at tensionless kinetochores stems from a 4-fold reduction of kinetochore turnover rate and requires aurora B kinase activity. (PMID:18065224)
- Stable hZW10 kinetochore residency at prometaphase kinetochores is dependent on its interaction with hZwint-1, and is essential for mitotic checkpoint arrest. (PMID:18268100)
- The interaction between ZW10 and dynamitin showed that the N-terminal region of ZW10 is the major binding site for dynamitin and, like full-length ZW10, could move along microtubules to the centrosomal area in a dynein-dynactin-dependent manner. (PMID:18782227)
- Results together suggest that NAG links between p31 and ZW10-RINT-1 and is involved in Golgi-to-ER transport. (PMID:19369418)
- hZwint-1 bridges the inner and outer kinetochore: identification of the kinetochore localization domain and the hZw10-interaction domain (PMID:21345172)
- The RZZ complex was purified to homogeneity and subjected to systemic crystallization. (PMID:25849506)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zw10 | ENSDARG00000018738 |
| mus_musculus | Zw10 | ENSMUSG00000032264 |
| rattus_norvegicus | Zw10 | ENSRNOG00000054479 |
| drosophila_melanogaster | Zw10 | FBGN0004643 |
| caenorhabditis_elegans | WBGENE00017643 |
Protein
Protein identifiers
Centromere/kinetochore protein zw10 homolog — O43264 (reviewed: O43264)
All UniProt accessions (2): O43264, F5H3C1
UniProt curated annotations — full annotation on UniProt →
Function. Essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis. Required for the assembly of the dynein-dynactin and MAD1-MAD2 complexes onto kinetochores. Its function related to the spindle assembly machinery is proposed to depend on its association in the mitotic RZZ complex. Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum (ER); the function is proposed to depend on its association in the interphase NRZ complex which is believed to play a role in SNARE assembly at the ER.
Subunit / interactions. Interacts with NBAS and KNTC1/ROD; the interactions are mutually exclusive and indicative for its association in two different vesicle tethering complexes. Component of the RZZ complex composed of KNTC1/ROD, ZW10 and ZWILCH. Component of the NRZ complex composed of NBAS, ZW10 and RINT1/TIP20L; NRZ associates with SNAREs STX18, USE1L, BNIP1/SEC20L and SEC22B (the assembly has been described as syntaxin 18 complex). Interacts directly with RINT1/TIP20L bound to BNIP1/SEC20L. Interacts with C19orf25 and ZWINT. Interacts with ZFYVE1. Interacts with RAB18 and this interaction is enhanced in the presence of ZFYVE1.
Subcellular location. Cytoplasm. Endoplasmic reticulum membrane. Chromosome. Centromere. Kinetochore. Cytoskeleton. Spindle. Lipid droplet.
Tissue specificity. Widely expressed.
Miscellaneous. Overexpression as well as silencing of ZW10 disrupts the morphology of the ER-Golgi intermediate compartment as well as the Golgi apparatus and slows down ER-Golgi transport.
Similarity. Belongs to the ZW10 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O43264-1 | 1 | yes |
| O43264-2 | 2 |
RefSeq proteins (1): NP_004715* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009361 | Zw10_N | Domain |
| IPR046362 | Zw10/DSL1_C_sf | Homologous_superfamily |
| IPR048343 | ZW10_C | Domain |
| IPR048344 | Zw10_middle | Domain |
| IPR055148 | ZW10_C_2 | Domain |
Pfam: PF06248, PF20665, PF20666, PF22766
UniProt features (11 total): modified residue 4, region of interest 2, initiator methionine 1, chain 1, sequence variant 1, coiled-coil region 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QPG | ELECTRON MICROSCOPY | 3.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O43264-F1 | 81.29 | 0.33 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 2, 3, 12, 777
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal |
| R-HSA-2467813 | Separation of Sister Chromatids |
| R-HSA-2500257 | Resolution of Sister Chromatid Cohesion |
| R-HSA-5663220 | RHO GTPases Activate Formins |
| R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic |
| R-HSA-68877 | Mitotic Prometaphase |
| R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation |
MSigDB gene sets: 238 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION, GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_REGULATION_OF_NUCLEAR_DIVISION, GOBP_SPINDLE_LOCALIZATION, GOBP_CHROMOSOME_LOCALIZATION, GOBP_CELL_CYCLE_PHASE_TRANSITION, GOBP_CHROMOSOME_SEPARATION, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_REGULATION_OF_EXIT_FROM_MITOSIS, REACTOME_MEMBRANE_TRAFFICKING, GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION, GOBP_ESTABLISHMENT_OF_CELL_POLARITY, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT
GO Biological Process (16): mitotic sister chromatid segregation (GO:0000070), establishment of mitotic spindle orientation (GO:0000132), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), Golgi organization (GO:0007030), mitotic metaphase chromosome alignment (GO:0007080), mitotic spindle assembly checkpoint signaling (GO:0007094), regulation of exit from mitosis (GO:0007096), protein transport (GO:0015031), protein localization to kinetochore (GO:0034501), cell division (GO:0051301), meiotic cell cycle (GO:0051321), regulation of attachment of spindle microtubules to kinetochore (GO:0051988), protein-containing complex assembly (GO:0065003), mitotic cell cycle (GO:0000278), vesicle-mediated transport (GO:0016192)
GO Molecular Function (2): centromeric DNA binding (GO:0019237), protein binding (GO:0005515)
GO Cellular Component (16): kinetochore (GO:0000776), spindle pole (GO:0000922), nucleus (GO:0005634), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), lipid droplet (GO:0005811), kinetochore microtubule (GO:0005828), cytosol (GO:0005829), membrane (GO:0016020), Dsl1/NZR complex (GO:0070939), RZZ complex (GO:1990423), chromosome, centromeric region (GO:0000775), chromosome (GO:0005694), cytoplasm (GO:0005737), spindle (GO:0005819), cytoskeleton (GO:0005856)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Mitotic Prometaphase | 2 |
| Amplification of signal from the kinetochores | 1 |
| Mitotic Anaphase | 1 |
| RHO GTPase Effectors | 1 |
| Golgi-to-ER retrograde transport | 1 |
| M Phase | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 5 |
| cellular anatomical structure | 4 |
| mitotic cell cycle | 3 |
| cytoplasm | 3 |
| mitotic nuclear division | 2 |
| mitotic cell cycle process | 2 |
| Golgi vesicle transport | 2 |
| transport | 2 |
| cellular process | 2 |
| cell cycle | 2 |
| intracellular membrane-bounded organelle | 2 |
| sister chromatid segregation | 1 |
| establishment of mitotic spindle localization | 1 |
| establishment of spindle orientation | 1 |
| intercellular transport | 1 |
| intracellular transport | 1 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| mitotic sister chromatid segregation | 1 |
| metaphase chromosome alignment | 1 |
| negative regulation of mitotic metaphase/anaphase transition | 1 |
| spindle assembly checkpoint signaling | 1 |
| mitotic spindle checkpoint signaling | 1 |
| exit from mitosis | 1 |
| regulation of mitotic cell cycle phase transition | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| protein localization to chromosome, centromeric region | 1 |
| protein localization to condensed chromosome | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| attachment of spindle microtubules to kinetochore | 1 |
| regulation of cell cycle process | 1 |
| cellular component assembly | 1 |
| protein-containing complex organization | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| binding | 1 |
| condensed chromosome, centromeric region | 1 |
| supramolecular complex | 1 |
Protein interactions and networks
STRING
1730 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZW10 | ZWILCH | Q9H900 | 999 |
| ZW10 | RINT1 | Q6NUQ1 | 997 |
| ZW10 | KNTC1 | P50748 | 995 |
| ZW10 | ZWINT | O95229 | 994 |
| ZW10 | ZNF787 | Q6DD87 | 945 |
| ZW10 | DCTN2 | Q13561 | 911 |
| ZW10 | INCENP | Q9NQS7 | 909 |
| ZW10 | RAB18 | Q9NP72 | 876 |
| ZW10 | STX18 | Q9P2W9 | 873 |
| ZW10 | BUB3 | O43684 | 852 |
| ZW10 | BUB1 | O43683 | 843 |
| ZW10 | SPDL1 | Q96EA4 | 835 |
| ZW10 | BUB1B | O60566 | 817 |
| ZW10 | CENPE | Q02224 | 812 |
| ZW10 | DSN1 | Q9H410 | 792 |
IntAct
199 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZWINT | NDC80 | psi-mi:“MI:0914”(association) | 0.940 |
| RINT1 | ZW10 | psi-mi:“MI:0915”(physical association) | 0.890 |
| RINT1 | NBAS | psi-mi:“MI:0914”(association) | 0.830 |
| STX18 | NBAS | psi-mi:“MI:0914”(association) | 0.810 |
| NBAS | ZW10 | psi-mi:“MI:0914”(association) | 0.720 |
| ZW10 | NBAS | psi-mi:“MI:0914”(association) | 0.720 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
BioGRID (204): ZW10 (Two-hybrid), ZW10 (Reconstituted Complex), ZW10 (Affinity Capture-MS), ZW10 (Affinity Capture-MS), ZW10 (Affinity Capture-MS), ZW10 (Affinity Capture-MS), ZW10 (Affinity Capture-MS), ACTR1A (Co-fractionation), ACTR1B (Co-fractionation), HSPA4 (Co-fractionation), KNTC1 (Co-fractionation), MSH2 (Co-fractionation), ZW10 (Affinity Capture-MS), ZW10 (Affinity Capture-MS), ZW10 (Affinity Capture-MS)
ESM2 similar proteins: A0JN62, A2RT67, A4IFB6, E1C3P4, F1QEB7, F1R7R1, O35099, O43264, O54921, O94967, P48553, P51593, Q08CL8, Q08CZ0, Q0VEJ0, Q28G25, Q3TLI0, Q4R350, Q5F3K0, Q5R9R1, Q5RFM4, Q5XH48, Q5XIA4, Q5ZIW2, Q641K1, Q6DE97, Q6NU53, Q6VNB8, Q7TMY8, Q7TSG1, Q7Z6Z7, Q8BH15, Q8CGF6, Q8IWR0, Q8IY22, Q8IZQ1, Q8K1X1, Q8N960, Q8QFR2, Q95LL7
Diamond homologs: O43264, O54692, Q4V8C2, Q5RFM4
SIGNOR signaling
3 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| ZW10 | “form complex” | “RZZ complex” | binding |
| ZW10 | “up-regulates activity” | DCTN2 | relocalization |
| ZW10 | “form complex” | “NRZ complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 154 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| COPI-dependent Golgi-to-ER retrograde traffic | 10 | 11.7× | 6e-06 |
| Amplification of signal from the kinetochores | 5 | 10.4× | 6e-03 |
| RHOQ GTPase cycle | 5 | 9.5× | 7e-03 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 7 | 8.6× | 4e-03 |
| COPI-mediated anterograde transport | 7 | 8.1× | 4e-03 |
| EML4 and NUDC in mitotic spindle formation | 7 | 6.8× | 6e-03 |
| RHO GTPases Activate Formins | 8 | 6.5× | 4e-03 |
| Resolution of Sister Chromatid Cohesion | 7 | 6.4× | 6e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 11 | 28.3× | 1e-10 |
| mitotic spindle assembly checkpoint signaling | 6 | 25.7× | 5e-05 |
| intra-Golgi vesicle-mediated transport | 5 | 20.1× | 1e-03 |
| endoplasmic reticulum to Golgi vesicle-mediated transport | 9 | 9.3× | 2e-04 |
| protein transport | 13 | 4.4× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
111 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 96 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2145 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:113736614:ACAT:A | donor_loss | 1.0000 |
| 11:113736616:ATAC:A | donor_loss | 1.0000 |
| 11:113736617:TA:T | donor_loss | 1.0000 |
| 11:113736618:A:AC | donor_gain | 1.0000 |
| 11:113736619:C:CC | donor_gain | 1.0000 |
| 11:113736619:CCGAT:C | donor_gain | 1.0000 |
| 11:113736769:CATCA:C | acceptor_gain | 1.0000 |
| 11:113736774:C:CC | acceptor_gain | 1.0000 |
| 11:113736829:T:C | acceptor_gain | 1.0000 |
| 11:113736832:C:CT | acceptor_gain | 1.0000 |
| 11:113737566:CCTTA:C | donor_loss | 1.0000 |
| 11:113737567:CTTA:C | donor_loss | 1.0000 |
| 11:113737568:TTA:T | donor_loss | 1.0000 |
| 11:113737569:TACC:T | donor_loss | 1.0000 |
| 11:113737570:A:AG | donor_loss | 1.0000 |
| 11:113738260:CTAC:C | donor_loss | 1.0000 |
| 11:113738262:A:AC | donor_gain | 1.0000 |
| 11:113738262:ACCTG:A | donor_gain | 1.0000 |
| 11:113738263:C:CC | donor_gain | 1.0000 |
| 11:113738263:C:CT | donor_loss | 1.0000 |
| 11:113738263:CCTG:C | donor_gain | 1.0000 |
| 11:113738263:CCTGC:C | donor_gain | 1.0000 |
| 11:113738266:G:A | donor_gain | 1.0000 |
| 11:113738283:G:A | donor_gain | 1.0000 |
| 11:113738390:TGTCC:T | acceptor_gain | 1.0000 |
| 11:113738391:GTCC:G | acceptor_gain | 1.0000 |
| 11:113738392:TCC:T | acceptor_gain | 1.0000 |
| 11:113738393:CC:C | acceptor_gain | 1.0000 |
| 11:113738393:CCCTA:C | acceptor_gain | 1.0000 |
| 11:113738394:CCTA:C | acceptor_gain | 1.0000 |
AlphaMissense
5152 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:113733739:A:C | F765L | 0.999 |
| 11:113733739:A:T | F765L | 0.999 |
| 11:113733741:A:G | F765L | 0.999 |
| 11:113737670:A:G | W640R | 0.999 |
| 11:113737670:A:T | W640R | 0.999 |
| 11:113739213:C:A | G585W | 0.999 |
| 11:113739334:G:C | N544K | 0.999 |
| 11:113739334:G:T | N544K | 0.999 |
| 11:113743873:A:C | S480R | 0.999 |
| 11:113743873:A:T | S480R | 0.999 |
| 11:113743875:T:G | S480R | 0.999 |
| 11:113733721:T:A | R771S | 0.998 |
| 11:113733721:T:G | R771S | 0.998 |
| 11:113737690:A:G | L633P | 0.998 |
| 11:113739337:G:C | N543K | 0.998 |
| 11:113739337:G:T | N543K | 0.998 |
| 11:113739350:G:T | A539D | 0.998 |
| 11:113747571:G:T | A411D | 0.998 |
| 11:113747572:C:G | A411P | 0.998 |
| 11:113733722:C:G | R771T | 0.997 |
| 11:113737657:A:G | L644P | 0.997 |
| 11:113733813:A:G | W741R | 0.996 |
| 11:113733813:A:T | W741R | 0.996 |
| 11:113738394:C:T | G585E | 0.996 |
| 11:113739213:C:G | G585R | 0.996 |
| 11:113739213:C:T | G585R | 0.996 |
| 11:113739333:A:G | C545R | 0.996 |
| 11:113747559:A:C | M415R | 0.996 |
| 11:113747567:T:A | R412S | 0.996 |
| 11:113747567:T:G | R412S | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000228374 (11:113740853 G>A,C), RS1000273690 (11:113764535 G>A), RS1000519907 (11:113741102 AC>A), RS1000521652 (11:113757369 A>G), RS1000531373 (11:113732836 C>T), RS1000559 (11:113774495 G>A,T), RS1000655419 (11:113738734 T>C), RS1000664495 (11:113769244 A>C,T), RS1000771414 (11:113768988 A>G), RS1000785870 (11:113771344 G>A), RS1000864709 (11:113745085 C>T), RS1000971766 (11:113752338 C>G), RS1001126796 (11:113759409 C>T), RS1001198413 (11:113737730 G>A,T), RS1001212085 (11:113768518 T>A,C,G)
Disease associations
OMIM: gene MIM:603954 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006701_17 | Parental longevity (father’s attained age) | 6.000000e-09 |
| GCST011100_15 | Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis) | 4.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007796 | parental longevity |
| EFO:0009762 | healthspan |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067040 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.26 | Kd | 54.37 | nM | CHEMBL5653589 |
| 7.26 | ED50 | 54.37 | nM | CHEMBL5653589 |
| 5.54 | Kd | 2901 | nM | CHEMBL3752910 |
| 5.54 | ED50 | 2901 | nM | CHEMBL3752910 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149819: Binding affinity to human ZW10 incubated for 45 mins by Kinobead based pull down assay | kd | 0.0544 | uM |
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149819: Binding affinity to human ZW10 incubated for 45 mins by Kinobead based pull down assay | kd | 2.9013 | uM |
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| 2,3-dimethoxy-1,4-naphthoquinone | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ivermectin | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Rotenone | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652861 | Binding | Binding affinity to human ZW10 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.